Chemoinformaics analysis of Sequiterpene lactone 326
| Molecular Weight | 264.321 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 18 |
| Exact Molecular Weight | 264.136 | nRing | 3 |
| Solubility: LogS | -1.863 | nHRing | 1 |
| Solubility: LogP | 0.616 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 41.5939 |
| nHD | 1 | BPOL | 23.5361 |
| QED | 0.533 |
| Synth | 4.651 |
| Natural Product Likeliness | 3.098 |
| NR-PPAR-gamma | 0.736 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0 |
| HIA | 0.018 |
| CACO-2 | -4.695 |
| MDCK | 0.0000206 |
| BBB | 0.854 |
| PPB | 0.736067 |
| VDSS | 0.807 |
| FU | 0.289823 |
| CYP1A2-inh | 0.029 |
| CYP1A2-sub | 0.563 |
| CYP2c19-inh | 0.057 |
| CYP2c19-sub | 0.873 |
| CYP2c9-inh | 0.035 |
| CYP2c9-sub | 0.548 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.274 |
| CYP3a4-inh | 0.199 |
| CYP3a4-sub | 0.621 |
| CL | 11.054 |
| T12 | 0.74 |
| hERG | 0.011 |
| Ames | 0.061 |
| ROA | 0.715 |
| SkinSen | 0.066 |
| Carcinogencity | 0.671 |
| EI | 0.084 |
| Respiratory | 0.754 |
| NR-Aromatase | 0.609 |
| Antiviral | Yes |
| Prediction | 0.742361 |